Chitosan-based microneedle arrays for dermal delivery of Centella asiatica

Copyright © 2022 Elsevier B.V. All rights reserved..

Centella asiatica, a medicinal herb used for wound healing, has a limited effect when delivered as an ointment. Centella asiatica's active component asiatic acid (AA) increases extracellular matrix development and reduces inflammation but cannot penetrate the stratum corneum to access deeper skin layers. To bypass the stratum corneum, we formulated two types of AA-loaded microneedle arrays. We fabricated, characterised and optimised a dissolving array made from chitosan and PVA and a hydrogel array made from chitosan and PVP. Both needles were strong and long enough to pierce the epidermis without breaking. Both were biocompatible with keratinocytes and fibroblasts (>75% viability at 100% concentration) and showed a sustained drug release over 48 h. The hydrogel microneedle released more AA (52.2%) than the dissolving formulation (26.4%); thus, we evaluated them in an excisional rat model. The hydrogel microneedle arrays significantly increased the rate of wound closure compared to the control. This research has shown that the chitosan-PVA hydrogel microneedles could penetrate the epidermis, effectively release AA, and increase the wound closure rate. This AA-loaded delivery system shows promise as a natural treatment for wound healing and may be applied to other bioactive compounds with similar physiochemical properties in the future.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:627

Enthalten in:

International journal of pharmaceutics - 627(2022) vom: 05. Nov., Seite 122221

Sprache:

Englisch

Beteiligte Personen:

Ryall, Cameron [VerfasserIn]
Chen, Shuo [VerfasserIn]
Duarah, Sanjukta [VerfasserIn]
Wen, Jingyuan [VerfasserIn]

Links:

Volltext

Themen:

9012-76-4
Asiatic acid
Centella asiatica extract
Chitosan
Dissolving microneedles
Hydrogel microneedles
Hydrogels
Journal Article
Ointments
Topical dermal delivery
Wound healing

Anmerkungen:

Date Completed 20.10.2022

Date Revised 20.10.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijpharm.2022.122221

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM346788234